Anatomical Therapeutic Chemical Classification System
E462927
The Anatomical Therapeutic Chemical Classification System is an internationally used drug classification system that organizes medicines into groups according to the organ or system they act on and their therapeutic and chemical characteristics.
Statements (50)
| Predicate | Object |
|---|---|
| instanceOf |
drug classification system
ⓘ
pharmaceutical classification system ⓘ |
| abbreviation | ATC NERFINISHED ⓘ |
| alsoKnownAs | ATC/DDD system NERFINISHED ⓘ |
| appliesTo | human medicines ⓘ |
| ATCvetAppliesTo | veterinary medicines ⓘ |
| classificationCriterion |
anatomical site of action
ⓘ
chemical characteristics ⓘ pharmacological properties ⓘ therapeutic properties ⓘ |
| combinedWith | Defined Daily Dose system NERFINISHED ⓘ |
| countryOfOrganization | Norway NERFINISHED ⓘ |
| developedBy | World Health Organization NERFINISHED ⓘ |
| exampleCodeRepresents | metformin ⓘ |
| fifthLevelExample | A10BA02 – Metformin NERFINISHED ⓘ |
| fifthLevelRepresents | chemical substance ⓘ |
| firstLevelExample | A – Alimentary tract and metabolism ⓘ |
| firstLevelRepresents | anatomical main group ⓘ |
| fourthLevelExample | A10BA – Biguanides NERFINISHED ⓘ |
| fourthLevelRepresents | chemical subgroup ⓘ |
| governedBy | ATC guidelines ⓘ |
| hasComponent | ATC code ⓘ |
| hasExampleCode | A10BA02 ⓘ |
| hasFormat | alphanumeric code ⓘ |
| hasLevel | five-level hierarchy ⓘ |
| hasVariant | ATCvet NERFINISHED ⓘ |
| introducedIn | 1970s ⓘ |
| languageOfOfficialVersion | English ⓘ |
| maintainedBy | World Health Organization Collaborating Centre for Drug Statistics Methodology NERFINISHED ⓘ |
| purpose |
classify drugs
ⓘ
organize medicines into groups ⓘ |
| relatedSystem | Defined Daily Dose ⓘ |
| secondLevelExample | A10 – Drugs used in diabetes ⓘ |
| secondLevelRepresents | therapeutic main group ⓘ |
| standardizedBy | World Health Organization guidelines ⓘ |
| thirdLevelExample | A10B – Oral blood glucose lowering drugs ⓘ |
| thirdLevelRepresents | pharmacological subgroup ⓘ |
| updatedBy | WHO Collaborating Centre for Drug Statistics Methodology NERFINISHED ⓘ |
| updateFrequency | annually ⓘ |
| usedBy |
healthcare payers
ⓘ
pharmaceutical industry ⓘ regulatory authorities ⓘ researchers ⓘ |
| usedFor |
comparative studies of drug use between countries
ⓘ
drug utilization research ⓘ formulary management ⓘ health statistics ⓘ pharmacoepidemiology ⓘ reimbursement systems ⓘ |
| usedIn | internationally ⓘ |
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.